Medical Countermeasures

Lovelace Biomedical has extensive experience in evaluating preclinical medical countermeasures research & studies against biological, chemical, radiological, and explosive threats, as well as combat casualty care. Lovelace has the ability to work with agents requiring containment and chemical surety (i.e. meets the minimum requirements for AR50-6 Chemical Surety) and CDC select agents in addition to our Nuclear Regulatory Commission (NRC)-approved facilities. We undertake regulated studies in efforts to complete FDA Animal Rule Investigational New Drugs (INDs) leading to full New Drug Application (NDA)/Biologic License Application (BLA) programs.

NIH FDA Presentation